Helen Albert

Helen is a freelance science journalist based in Berlin, Germany. Specialising in healthcare, life sciences, bioanthropology, biotech and innovation. 

Highlighted Work

Inside Precision Medicine •

The Slow and Winding Path to Pharmacogenomic Test Adoption

A cornerstone of precision medicine, pharmacogenomic testing allows drug treatment for a disease to be tailored to a person’s genetic makeup. Despite a large amount of research having been carried out in this area from the 1990s onward, only a few of the findings have reached the clinic in the form of tests.
High costs, unreliable data, and a lack of physician education have been cited as reasons for this slow adoption, but recent developments like improvements in data and guidelines, reductions...
Chemistry World •

Ten years on, pharma industry still testing for implausible alkyl sulfonate ester contaminants

A decade after concerns about the necessity of testing for alkyl sulfonate esters in drugs were raised1, risk assessment for this potentially mutagenic contaminant is still required by UK and European drug standard authorities.2 Other major standards bodies, such as the US and Japanese ones, do not have similar requirements for sulfonate-salt drugs.
In 2004, the European Pharmacopoeia of pharmaceutical standards introduced a requirement for sulfonate salt drug substances, stipulating that manuf...
Chemistry World •

Europe and US face diminishing lithium supply for electric vehicle batteries

Lithium supplies in Europe and the US will not meet demand for electric vehicle batteries by 2030, despite significant predicted increases in production over this time, new research suggests.
China is predicted to continue its control of the market with greater access to imported lithium and better refining capacity than other regions, as well as a large domestic electric battery industry.
‘China is currently completely dominating,’ explains André Månberger, study co-author and senior lecturer...
Inside Precision Medicine •

Harnessing AI Innovation to Modernize Clinical Trials

Clinical trials are an essential part of bringing new medicines to patients but are often slow and expensive to complete. Innovations in artificial intelligence (AI) over the last two decades are already having a positive impact on the way these trials are run and have the potential to improve them further in many ways, ranging from simple economics to more diverse trial cohorts.
The first randomized controlled clinical trial is generally agreed to have taken place in 1946 in the U.K. to test th...
Chemistry World •

Less than 10% of plastics are produced using recycled materials

An analysis of the global plastics industry shows that only 9.5% of plastic was made from recycled materials in 2022. Almost a third of plastic waste produced during that year was allocated for recycling, but only half was actually recycled. ‘The low recycling rate is due to a number of challenges including plastic diversity, contamination and economic barriers,’ explains lead author Quanyin Tan at Tsinghua University in Beijing.
The amount of plastic produced globally has increased from 2 mill...
Advanced Science News •

Sustainable building material extracted from seawater

A seashell inspired material that locks away carbon dioxide could make concrete more sustainable.  The process to make this material involves splitting seawater using carbon dioxide and electricity and can also be used to produce hydrogen for fuel adding an additional benefit to the method.


“This research develops a method to capture, convert, and store carbon dioxide in the form of solid minerals, which can be incorporated as supplementary materials in concrete,” said Alessandro Rotta Loria,...
Inside Precision Medicine •

Tackling Autoimmune Disease with Cell and Gene Therapy

Over the last decade, the cell and gene therapy space has changed beyond recognition. The field has experienced ups and downs, but such advanced therapeutics are becoming more mainstream and moving into spaces outside cancer and rare diseases.
At the end of 2015, only three cell and gene therapy products had been approved by the FDA. By the end of 2024, this figure had increased to 43 products, with more therapies approved every year.
Notable successes to date are chimeric antigen receptor (CAR)...
Advanced Science News •

High yield, eco-friendly rice reduces methane emissions by 70%

A group of scientists have bred a new variety of rice that could help combat rising methane levels around the world.  


“Methane has a very strong impact. It’s around 20 times stronger than carbon dioxide,” explained Anna Schnürer, a microbiologist at the Swedish University of Agricultural Sciences and one of the contributing scientists. “Rice field cultivation corresponds to approximately 13% of the methane that humans are releasing into the atmosphere. So, it’s having a significant effect on...
Inside Precision Medicine •

Pulling Antimicrobial Innovation Forward One Step at a Time

Antimicrobial drugs have saved billions of lives over the last century, but during the last 30 years, deaths due to antimicrobial resistance (AMR) have increased exponentially. While there are many early-stage companies and researchers working to bring new treatments and diagnostics to market, success seems difficult due to reimbursement issues.
The ability of some pathogenic bacteria to resist antibiotics became clear shortly after drugs like penicillin began to be produced in large quantities...
Inside Precision Medicine •

In Conversation with Vanessa Carter and Sue Charles

Antimicrobial resistance (AMR) remains a challenging and life-threatening global health problem, despite some progress in tackling the problem over the last decade. Listening to stories from patients who have survived AMR can help to humanize the issue and really make people understand the problem.
AMR was declared a global emergency by the World Health Organization (WHO) in 2015, with the first global action plan and United Nations General Assembly high-level meeting occurring in 2016.
Since th...
Inside Precision Medicine •

Building a Precision Medicine Ecosystem in Africa

African populations are not well represented in genomic research, despite the enormous amount of genetic variation present in African populations. This gap makes it harder to develop fair and effective precision medicine programs that work for everyone.
Lack of funding and infrastructure in the region has made it hard to establish local programs in Africa in the past, but things are changing. Genomics and the early stages of precision medicine are now being set up in a number of countries on the...
Inside Precision Medicine •

Uncovering the Mysteries of the Gut–Brain Connection

Links between the gut and the brain were discovered many years ago, but what role does the gut microbiome play in this relationship? Recent research suggests that disruption of or abnormal activity in the gut microbiome may increase our risk for neurological disease, but whether this knowledge can be harnessed to treat, diagnose, or monitor such conditions remains to be seen.
Research into the physiology of the gut–brain connection largely began in the 19th century. In the 1840s, William Beaumon...
Inside Precision Medicine •

Applying Precision Technology to Tackle Climate-Driven Infectious Diseases

The devastating impact that infectious diseases can have on the global population was well demonstrated by the COVID-19 pandemic. Fortunately, pandemics remain unusual occurrences, but research suggests that factors such as climate change may be increasing the risk of such events occurring in the future.
In a pre-pandemic study published in 2016, infectious disease researcher Jan Semenza, PhD, currently based at Umeå University in Sweden, and colleagues assessed potential drivers of infectious d...
Inside Precision Medicine •

Breaking Down Sex and Gender Barriers in Search of Precision Medicine

Biological sex and gender have a large impact on the presentation of a disease, its progression, and how it is treated, but these factors have not received adequate research or clinical attention. Positive signs of change are emerging, but there is a lot that needs to be achieved before these benefits can reach a wide range of patients.

To achieve true precision medicine, many potential factors need to be considered. An important example of this is a person’s biological sex and gender.

“Intuit
Chemistry World •

Bioelectric bacteria-powered sensor detects water contaminants in real time

Synthetic biology has been combined with electrical engineering to create a small bioelectric sensor that can sense water contaminants in just minutes.

The sensor is currently at the prototype stage and is not yet being produced commercially, but has already been used to detect thiosulfate, known to cause algal blooms, within 2 minutes and also the endocrine disruptor 4-hydroxytamoxifen (4-HT) within 3 minutes.

Detection methods for these environmental pollutants, and others such as nitrates a
Inside Precision Medicine •

Genomic Pathogen Surveillance in the Spotlight

The COVID-19 pandemic has really highlighted the need for effective genomic pathogen surveillance and allowed researchers around the world to hone their skills and technology. While these advances are not in doubt, whether they are maintained and used to help prevent new pandemics and fight global threats such as antimicrobial resistance remains to be seen.

Over the last decade, huge advances in technology have made genomic sequencing cheaper and more accessible, facilitating the tracking of ba
Labiotech.eu •

Nature’s Painters: Making Sustainable Colors with Microbes

The production of textile dyes and food colorants can have a big environmental footprint. Biotech startups are rising to the challenge by engineering bacteria, fungi, and algae to sustainably produce natural colors.

Eight years ago, University of Cambridge researcher Jim Ajioka was in Nepal helping to produce a biosensor to detect arsenic in drinking water and was shocked at how poor the water quality was in the region.

“In Kathmandu, all of the textile industry just dumps its waste straight i
New Scientist •

Investigation fails to replicate most cancer biology lab findings

The reliability of early-stage cancer biology research is called into question by an investigation that concludes more than half of experimental results can’t be replicated by independent scientists

Lab-based cancer research isn’t always easy to replicate, according to a new investigation

An eight-year-long investigation into the reliability of preclinical cancer biology research has found that fewer than half of the results published in 23 highly cited papers could be successfully reproduced.
Labiotech.eu •

What the EU's Single-Use Plastics Ban Means for the Bioplastics Industry

A European directive banning a range of single-use plastics came into law this month. How are the new regulations impacting industrial biotech companies developing bioplastics?

In an attempt to reduce staggeringly high levels of plastic pollution seen around the world, particularly in marine environments, the 27 EU member states and Norway agreed in 2019 to restrict ‘single-use plastics’ from being produced and sold in the EU.

The countries were given two years to implement the new regulations
Photo by Pok Rie on Pexels
Biodesigned •

Prophet in the Sewer — Biodesigned

Environmental engineer Smruthi Karthikeyan started her postdoc with Rob Knight at the University of California San Diego (UCSD) in March 2020 only days before the state implemented its first Covid lockdown.

“I haven’t met most of my colleagues,” she told me.

Starting a new job during a pandemic is not ideal, but Karthikeyan was soon offered an unexpected opportunity. “I was mostly working on computational stuff, and then one day, my principal investigator called me saying, ‘You're an environme
Labiotech.eu •

Biomaterials Are Making the Building Industry More Sustainable

There is a growing awareness of the waste and pollution caused by the building industry. New biomaterials are being created using waste products and microbes to solve these ecological problems.

“Using biological materials in buildings isn’t a new concept – we’ve built wooden structures for thousands of years,” said Gavin McIntyre, co-founder and Director of Business Development at Ecovative Design, a US-based biotech making materials with mycelium — part of the root system of mushrooms.

Increa
New Scientist •

Earphone cameras watch your facial expressions and read your lips

A wearable device consisting of two mini-cameras mounted on earphones can recognise your facial expressions and read your lips, even if your mouth is covered.

The tool – called C-Face – was developed by Cheng Zhang at Cornell University in Ithaca, New York, and his colleagues. It looks at the sides of the wearer’s head and uses machine learning to accurately visualise facial expressions by analysing small changes in cheek contour lines.

“With previous technology to reconstruct facial expressio
British Medical Journal •

What will it take for Germany to embrace digital health?

Germans are not fast adopters of digital technology. With a fondness for using cash and low uptake of social media compared with most countries, they fiercely guard their right to control how personal information, including health records, is shared.1 When the independent foundation Bertelsmann Stiftung compiled an index measuring 17 countries’ progress in healthcare digitisation in 2019, Germany ranked second from the bottom (the UK came sixth).2

But 2020 is proving a time of change. Jörg Deba

Follow Me